Novo Nordisk’s Oral Semaglutide Achieves 16.6% Weight Loss In OASIS 4 Phase 3 Trial

(RTTNews) – Novo Nordisk (NVO) has released results from its OASIS 4 Phase 3 trial, highlighting…

Lilly’s Orforglipron Achieves Significant Weight Loss In Phase 3 Trial

(RTTNews) – Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial,…

SoundHound AI Q1: Buy It Fearlessly At A Small Weight (Upgrade) (NASDAQ:SOUN)

This article was written by Follow Oliver Rodzianko is a macro-focused investment analyst with a global…

WeightWatchers Files for Bankruptcy to Reduce $1 Billion in Debt

WeightWatchers, a 62-year-old health and wellness company that has faced stiff competition from new weight-loss drugs…

The Weight of the Internet Will Shock You

The internet is massive. But does it have … actual mass? Big server farms and miles…

Sam Altman Says OpenAI Will Release an ‘Open Weight’ AI Model This Summer

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the…